Persistent donor derived Vδ4 T cell clones may improve survival for recurrent T cell acute lymphoblastic leukemia after HSCT and DLI

The outcome for T-cell acute lymphoblastic leukemia (T-ALL) in relapse after hematopoietic stem cell transplantation (HSCT) is quite poor, while, both donor lymphocytes infusion (DLI) and adoptively infusion of γδ T cells in leukemia patients after HSCT have demonstrated good results in prolonging s...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Xu, Ling, Weng, Jianyu, Huang, Xin, Zeng, Chengwu, Chen, Shaohua, Geng, Suxia, Yang, Lijian, Wu, Suijing, Huang, Suming, Du, Xin, Li, Yangqiu
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2016
Assuntos:
Research Paper: Immunology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5189998/
https://ncbi.nlm.nih.gov/pubmed/27356746
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.10260
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados